These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 13548941)

  • 1. The ethical pharmaceutical manufacturer and the hospital pharmacy.
    MEES JL
    Hosp Manage; 1958 Jul; 86(1):86 passim. PubMed ID: 13548941
    [No Abstract]   [Full Text] [Related]  

  • 2. Unethical behavior in an ethical industry? Critical coverage of the pharmaceutical industry, 1983-1984.
    Mac Sheoin T
    Int J Health Serv; 1986; 16(1):141-62. PubMed ID: 3514496
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacy and the pharmaceutical industry.
    Ivey MF
    Am J Hosp Pharm; 1977 Jan; 34(1):16-21. PubMed ID: 831468
    [No Abstract]   [Full Text] [Related]  

  • 4. [Is the pharmaceutical industry really as bad as its reputation?].
    Prat EH
    Wien Med Wochenschr; 2005 Nov; 155(21-22):502-12. PubMed ID: 16425111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacists and industry: guidelines for ethical interactions.
    ; Hatton RC; Chavez ML; Jackson E; Maurey J; Barriere SL; Couchenour R; Evens RP; Gunning K; Hume AL; Hutchison LC; Matzke GR; Noviasky JA; Rospond RM; Kelloway JS; Stevenson JG; Vanderveen RP; Verme-Gibboney CN; Walters D
    Pharmacotherapy; 2008 Mar; 28(3):410-20. PubMed ID: 18294122
    [No Abstract]   [Full Text] [Related]  

  • 6. Ethical concerns arising from industry/practitioner relationship.
    Hall K
    Can J Hosp Pharm; 1987 Apr; 40(2):73-4. PubMed ID: 10282092
    [No Abstract]   [Full Text] [Related]  

  • 7. Beware of pharmaceutical garbage.
    MORAVEC DF
    Hosp Manage; 1959 Aug; 88(2):73-4 passim. PubMed ID: 13672555
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmaceutical manufacturer's stake in the prescription department.
    BURGHER VA
    Am J Pharm Sci Support Public Health; 1954 May; 126(5):171-6. PubMed ID: 13171460
    [No Abstract]   [Full Text] [Related]  

  • 9. Psychiatric training program engagement with the pharmaceutical industry: an educational issue, not strictly an ethical one.
    Mohl PC
    Acad Psychiatry; 2005; 29(2):215-21. PubMed ID: 15937270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmaceutical industry: challenge of the twentyfirst century.
    Daniel G
    Nurs J India; 1985 Jul; 76(7):178-9, 92. PubMed ID: 3852316
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmaceutical manufacturer and physician; partners in progress.
    KLUMPP TG
    J Mich State Med Soc; 1956 May; 55(5):565-9. PubMed ID: 13320089
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug information: from education to practice.
    Bernknopf AC; Karpinski JP; McKeever AL; Peak AS; Smith KM; Smith WD; Timpe EM; Ward KE
    Pharmacotherapy; 2009 Mar; 29(3):331-46. PubMed ID: 19249951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacy and pharmaceutical industry in Iran].
    Ladygin SI
    Farmatsiia; 1968; 17(1):92-3. PubMed ID: 5706506
    [No Abstract]   [Full Text] [Related]  

  • 14. The medical profession and the pharmaceutical industry: when will we open our eyes?
    Graudins LV
    Med J Aust; 2004 Oct; 181(8):458-9. PubMed ID: 15612085
    [No Abstract]   [Full Text] [Related]  

  • 15. Early U. S. pharmaceutical catalogues.
    GRIFFENHAGEN GB; ROMAINE LB
    Am J Pharm Sci Support Public Health; 1959 Jan; 131(1):14-33. PubMed ID: 13627141
    [No Abstract]   [Full Text] [Related]  

  • 16. The hidden costs of free lunches: fraud and abuse in physician-pharmaceutical arrangements.
    Gosfield AG
    J Med Pract Manage; 2005; 20(5):253-8. PubMed ID: 15921138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacy through the ages. Tonic aphrodisiac.
    Worthen DB
    J Am Pharm Assoc (2003); 2004; 44(2):225. PubMed ID: 15098854
    [No Abstract]   [Full Text] [Related]  

  • 18. Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors.
    Edwards D; Ballantyne A
    Intern Med J; 2009 Mar; 39(3):191-6. PubMed ID: 19383067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problems concerning the pharmacist & industry; conclusion on the studies made during the level of training of pharmacy inspectors].
    Prod Pharm; 1957 Apr; 12(4):274-6. PubMed ID: 13432050
    [No Abstract]   [Full Text] [Related]  

  • 20. The QUALITY control laboratory of the ethical pharmaceutical manufactrurer.
    Can Med Assoc J; 1960 Mar; 82(13):680-1. PubMed ID: 13856945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.